HomeANVS • NYSE
add
Annovis Bio Inc
Previous close
$6.79
Day range
$6.62 - $6.95
Year range
$4.53 - $22.49
Market cap
91.75M USD
Avg Volume
317.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.39M | -70.48% |
Net income | -12.64M | 14.12% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.64M | 98.85% |
Total assets | 14.36M | 40.48% |
Total liabilities | 7.30M | 104.71% |
Total equity | 7.06M | — |
Shares outstanding | 13.80M | — |
Price to book | 12.81 | — |
Return on assets | -113.04% | — |
Return on capital | -412.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.64M | 14.12% |
Cash from operations | -3.20M | 65.83% |
Cash from investing | — | — |
Cash from financing | 11.84M | — |
Net change in cash | 8.64M | 192.20% |
Free cash flow | -1.69M | 57.10% |
About
Founded
2008
Headquarters
Website
Employees
6
